Literature DB >> 30368582

Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Jonna M Leyrer-Jackson1, Erin K Nagy1, M Foster Olive2.   

Abstract

RATIONALE: The number of synthetic derivatives of cathinone, the primary psychoactive alkaloid found in Catha edulis (khat), has risen exponentially in the past decade. Synthetic cathinones (frequently referred to as "bath salts") produce adverse cognitive and behavioral sequelae, share similar pharmacological mechanisms of action with traditional psychostimulants, and may therefore trigger similar cellular events that give rise to neuroinflammation and neurotoxicity.
OBJECTIVES: In this review, we provide a brief overview of synthetic cathinones, followed by a summary of cognitive deficits in animals and humans that have been documented following acute or repeated exposure. We also summarize growing evidence from in vitro and in vivo studies for synthetic cathinone-induced neurotoxicity, and provide a working hypothetic model of potential cellular mechanisms.
RESULTS: Synthetic cathinones produce varying effects on markers of monoaminergic terminal function and can increase the formation of reactive oxygen and nitrogen species, induce apoptotic signaling, and cause neurodegeneration and cytotoxicity. We hypothesize that these effects result from biochemical events similar to those induced by traditional psychostimulants. However, empirical evidence for the ability of synthetic cathinones to induce neuroinflammatory processes is currently lacking.
CONCLUSIONS: Like their traditional psychostimulant counterparts, synthetic cathinones appear to induce neurocognitive dysfunction and cytotoxicity, which are dependent on drug type, dose, frequency, and time following exposure. However, additional studies on synthetic cathinone-induced neuroinflammation are clearly needed, as are investigations into the neurochemical and neuroimmune mechanisms underlying their neurotoxic effects. Such endeavors may lead to novel therapeutic avenues to promote recovery in habitual synthetic cathinone users.

Entities:  

Keywords:  Abuse; Cognitive deficits; Designer drug; Neuroinflammation; Neurotoxicity; Psychostimulant; Synthetic cathinone

Mesh:

Substances:

Year:  2018        PMID: 30368582      PMCID: PMC6486871          DOI: 10.1007/s00213-018-5067-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  122 in total

Review 1.  Neuroadaptive effects of active versus passive drug administration in addiction research.

Authors:  Edwin H Jacobs; August B Smit; Taco J de Vries; Anton N M Schoffelmeer
Journal:  Trends Pharmacol Sci       Date:  2003-11       Impact factor: 14.819

Review 2.  Khat a drug of abuse: roles of free radicals and antioxidants.

Authors:  Samir L Aleryani; Rowaida A Aleryani; Ahmed A Al-Akwa
Journal:  Drug Test Anal       Date:  2010-12-02       Impact factor: 3.345

Review 3.  Neuroplastic alterations in the limbic system following cocaine or alcohol exposure.

Authors:  Garret D Stuber; F Woodward Hopf; Kay M Tye; Billy T Chen; Antonello Bonci
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 4.  To scale or not to scale: the principles of dose extrapolation.

Authors:  Vijay Sharma; John H McNeill
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

5.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

6.  Effects of single daily khat (Catha edulis) extract on spatial learning and memory in CBA mice.

Authors:  Samuel Thuu Kimani; Albert Wafula Nyongesa
Journal:  Behav Brain Res       Date:  2008-06-06       Impact factor: 3.332

7.  Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.

Authors:  David M Thomas; Jennifer Dowgiert; Timothy J Geddes; Dina Francescutti-Verbeem; Xiuli Liu; Donald M Kuhn
Journal:  Neurosci Lett       Date:  2004-09-09       Impact factor: 3.046

Review 8.  Ecstasy: are animal data consistent between species and can they translate to humans?

Authors:  Neil Easton; Charles A Marsden
Journal:  J Psychopharmacol       Date:  2006-03       Impact factor: 4.153

9.  Khat use is associated with impaired working memory and cognitive flexibility.

Authors:  Lorenza S Colzato; Manuel J Ruiz; Wery P M van den Wildenberg; Bernhard Hommel
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

10.  Long-term effects of chronic khat use: impaired inhibitory control.

Authors:  Lorenza S Colzato; Manuel J Ruiz; Wery P M van den Wildenberg; Maria Teresa Bajo; Bernhard Hommel
Journal:  Front Psychol       Date:  2011-01-12
View more
  7 in total

1.  Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.

Authors:  Michal Ordak; Aleksandra Zmysłowska; Miłosz Bielski; Daniel Rybak; Maja Tomaszewska; Katarzyna Wyszomierska; Aleksandra Kmiec; Natalia Garlicka; Maria Zalewska; Michal Zalewski; Tadeusz Nasierowski; Elzbieta Muszynska; Magdalena Bujalska-Zadrozny
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

2.  A Scientometric Visualization Analysis for Molecular Mechanisms of Substance Abuse and Its Neurotoxicity From 1997 to 2021.

Authors:  Aijia Zhang; Zilong Liu; Man Liang
Journal:  Front Mol Neurosci       Date:  2022-07-01       Impact factor: 6.261

3.  Poor Sleep in Community-Dwelling Polysubstance Users: Association With Khat Dependence, Metacognition, and Socio-Demographic Factors.

Authors:  Md Dilshad Manzar; Ahmad H Alghadir; Masood Khan; Mohammed Salahuddin; Hamid Yimam Hassen; Ahmed M Almansour; Dejen Nureye; Eyob Tekalign; Showkat Ahmad Shah; Seithikurippu R Pandi-Perumal; Ahmed S Bahammam
Journal:  Front Psychiatry       Date:  2022-05-10       Impact factor: 5.435

4.  The clinical challenges of synthetic cathinones.

Authors:  Fabrizio Schifano; Flavia Napoletano; Davide Arillotta; Caroline Zangani; Liam Gilgar; Amira Guirguis; John Martin Corkery; Alessandro Vento
Journal:  Br J Clin Pharmacol       Date:  2020-02-03       Impact factor: 4.335

5.  The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.

Authors:  Mona Khorani; Gerd Bobe; Donald G Matthews; Armando Alcazar Magana; Maya Caruso; Nora E Gray; Joseph F Quinn; Jan F Stevens; Amala Soumyanath; Claudia S Maier
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

6.  Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances.

Authors:  Valeria Sogos; Paola Caria; Clara Porcedda; Rafaela Mostallino; Franca Piras; Cristina Miliano; Maria Antonietta De Luca; M Paola Castelli
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 7.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.